Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas

被引：3
|
作者：
Butt, B. P. [1 ]
Stokmo, H. L. [2 ]
Ladekarl, M. [3 ]
Tabaksblat, E. Mitkina [4 ]
Sorbye, H. [5 ]
Revheim, M. E. [6 ]
Hjortland, G. O. [1 ]
机构：
[1] Oslo Univ Hosp, ENTES Neuroendocrine Tumor Ctr Excellence, Dept Oncol, Oslo, Norway
[2] Oslo Univ Hosp, Div Radiol & Nucl Med, Dept Nucl Med, Oslo, Norway
[3] Aalborg Univ Hosp, Clin Canc Res Ctr, Dept Oncol, Aalborg, Denmark
[4] Aarhus Univ Hosp, ENETS Neuroendocrine Tumor Ctr Excellence, Dept Oncol, Aarhus, Denmark
[5] Haukeland Univ Sykehus, Dept Clin Sci, Dept Oncol, Bergen, Norway
[6] Oslo Univ Hosp, ENETS Neuroendocrine Tumor Ctr Excellence, Inst Clin Med, Dept Nucl Med,Div Radiol & Nucl Med, Oslo, Norway
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1108P
引用
收藏
页码：S915 / S915
页数：1
相关论文
共 50 条
  • [31] Resistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors
    Beyens, Matthias
    Vandamme, Timon
    Peeters, Marc
    Van Camp, Guy
    Op de Beeck, Ken
    ENDOCRINE-RELATED CANCER, 2019, 26 (03) : R109 - R130
  • [32] Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma
    Thomas, Katharine E. H.
    Voros, Brianne A.
    Boudreaux, J. Philip
    Thiagarajan, Ramcharan
    Woltering, Eugene A.
    Ramirez, Robert A.
    ONCOLOGIST, 2019, 24 (08): : 1076 - 1088
  • [33] Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors
    Naraev, Boris G.
    Mailman, Josh
    Halfdanarson, Thorvardur R.
    Soares, Heloisa P.
    Mittra, Erik S.
    Hallet, Julie
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (06) : 601 - 615
  • [34] Everolimus in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Neoplasm: A Single-Center Retrospective Study in China
    Zhang, Y.
    Chen, L.
    Chen, M.
    Chen, J.
    NEUROENDOCRINOLOGY, 2016, 103 : 86 - 86
  • [35] Study on the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors: Traditional Chinese Medicine Combined With Somatostatin Analogues
    Qiu, Xudong
    Qi, Zhirong
    Li, Yuanliang
    Tan, Huangying
    PANCREAS, 2020, 49 (03) : 484 - 484
  • [36] Avelumab in Advanced Neuroendocrine Tumours (NET) of Gastroenteropancreatic or Lung Origin
    Chan, David
    Cheema, Parneet
    Hsieh, Eugene
    Law, Calvin
    Hallet, Julie
    Myrehaug, Sten
    Pugh, Trevor
    Siu, Lillian
    Spreafico, Anna
    Singh, Simron
    PANCREAS, 2018, 47 (03) : 334 - 334
  • [37] NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms
    Sorbye, H.
    Hjortland, G. O.
    Vestermark, L. W.
    Sundlov, A.
    Assmus, J.
    Couvelard, A.
    Perren, A.
    Langer, S. W.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 (11)
  • [38] Proposal of a treatment algorithm for the management of gastroenteropancreatic neuroendocrine tumors
    Bajetta, Emilio
    TUMORI, 2010, 96 (05) : 852 - 855
  • [39] Advances in the treatment of gastroenteropancreatic neuroendocrine neoplasms with somatostatin analogs
    Lu, Ming
    Zhang, Panpan
    Zhang, Jianwei
    Li, Jie
    JOURNAL OF PANCREATOLOGY, 2023, 6 (01) : 23 - 27
  • [40] New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
    Yin, Feng
    Wu, Zi-Hao
    Lai, Jin-Ping
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (17) : 1751 - 1767
12345